TY - JOUR
T1 - Emerging therapeutic options for B-cell disorders
T2 - idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.
AU - Goodrich, Amy
PY - 2007/2/1
Y1 - 2007/2/1
N2 - B-cell disorders include a large group of malignant and nonmalignant diseases with tremendous variation in incidence, natural history, treatment, and prognosis. This article will focus on adult idiopathic thrombocytopenic purpura (ITP) and chronic lymphocytic leukemia (CLL). Clinicians must individualize treatment for ITP and CLL to each patient. Observation without intervention is appropriate for some patients, whereas immediate treatment is indicated for others. Deciding when to treat and which agents to use can be difficult, but new therapeutic options are emerging for both conditions.
AB - B-cell disorders include a large group of malignant and nonmalignant diseases with tremendous variation in incidence, natural history, treatment, and prognosis. This article will focus on adult idiopathic thrombocytopenic purpura (ITP) and chronic lymphocytic leukemia (CLL). Clinicians must individualize treatment for ITP and CLL to each patient. Observation without intervention is appropriate for some patients, whereas immediate treatment is indicated for others. Deciding when to treat and which agents to use can be difficult, but new therapeutic options are emerging for both conditions.
UR - http://www.scopus.com/inward/record.url?scp=34248573614&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34248573614&partnerID=8YFLogxK
M3 - Article
C2 - 17474175
AN - SCOPUS:34248573614
SN - 1092-1095
VL - 11
SP - 23
EP - 36
JO - Clinical journal of oncology nursing
JF - Clinical journal of oncology nursing
IS - 1 Suppl
ER -